|
|
||||||||
Department of Surgery, The University of Texas Southwestern Medical Center, Dallas, Texas 75390-9160
| |
ABSTRACT |
|---|
|
|
|---|
Whereas hypertonic saline-dextran (HSD, 7.5%
NaCl in 6% D70) improves cardiac contractile function after burn
trauma, the mechanisms of HSD-related cardioprotection remain unclear.
We recently showed that cardiomyocytes secrete tumor necrosis
factor-
(TNF-
), a response that was enhanced by burn trauma. This
study addressed the question: does HSD modulate cardiac
contraction/relaxation by altering cardiomyocyte TNF-
secretion?
Wistar-Furth rats (325 g) were given a burn injury over 40% of the
total body surface area and were then randomized to receive a bolus of
either isotonic saline or HSD (4 ml/kg, n = 14 rats/group). Sham burn rats were given either isotonic saline or HSD
(n = 14 rats/group) to provide appropriate controls for
the two burn groups. Hearts were isolated 24 h postburn for either
Langendorff perfusion (n = 8 hearts/group) or to
prepare cardiomyocytes (n = 6 hearts/group). Myocytes
were stimulated with lipopolysaccharide (LPS) (0, 10, 25, or 50 µg for 18 h) to measure cytokine secretion. Burn trauma
increased myocyte TNF-
and interleukin-1
and -6 secretion,
exacerbated cytokine response to LPS stimulus, and impaired cardiac
contraction. HSD treatment of burns decreased cardiomyocyte cytokine
secretion, decreased responsiveness to LPS challenge with regard to
cytokine secretion, and improved ventricular function. These data
suggest that HSD mediates cardioprotection after burn trauma, in part, by downregulating cardiomyocyte secretion of inflammatory cytokines.
cardiac contractile function; rat model of burn trauma; tumor necrosis factor-
; Langendorff perfusion
| |
INTRODUCTION |
|---|
|
|
|---|
CONSIDERABLE CONTROVERSY has arisen regarding prehospital administration of isotonic fluids to resuscitate the severely injured patient. Problems cited have included difficulties in administering sufficient volumes of crystalloid during transport to stabilize arterial blood pressure and cardiac output, whereas other investigators have suggested that rapid and aggressive crystalloid resuscitation may alter clotting mechanisms and exacerbate blood loss in patients with uncontrolled hemorrhage (3, 10, 28, 30, 32, 36, 42, 46). Whereas large-volume crystalloid resuscitation has been used successfully during the last 30 years to resuscitate severely injured patients with few reports of complications (29, 42), the search for alternative regimens of fluid resuscitation continues. Holcroft and colleagues (14) described the successful resuscitation of severely injured patients with hypertonic sodium chloride-6% Dextran 70 (HSD). The use of HSD has been shown to be a particularly effective resuscitation strategy in experimental models of bile-induced pancreatitis, hemorrhagic shock, burn trauma, and septic shock (5, 9, 12, 14, 17, 20, 26, 27, 41, 47, 48). Small-volume HSD (4 ml/kg) has been shown to support circulation of the injured patient during transport, to improve blood pressure and cardiac output in clinical and experimental shock, to improve cardiac contractile performance in burn trauma, and to improve survival in lethal models of hemorrhagic shock. The beneficial effects of HSD have been attributed to reduced total fluid requirements, improved cardiac contractility, reduced diuresis by vasopressin-induced water reabsorption, and improved immunologic responses to stress-related injury (5, 9, 12, 14, 20, 26, 27, 41, 47, 48).
Recent attention has focused on the role of HSD as an effective
modulator of cell immune function after trauma. Several studies have
shown that, whereas crystalloid resuscitation exacerbated shock-mediated cellular adhesion and numerous aspects of the
shock-related inflammatory cascade, there was a remarkable absence of
exaggerated inflammatory responses with HSD resuscitation
(43). Recent focus on the immunologic consequences of HSD
resuscitation of trauma led us to compare the effects of standard
lactated Ringer solution resuscitation from burn trauma with
reduced-volume lactated Ringer solution resuscitation plus HSD on
postburn cardiac contractile performance and the cardiac synthesis of
inflammatory cytokines. Tumor necrosis factor-
(TNF-
) is clearly
recognized as an inflammatory mediator synthesized by cells within the
reticuloendothelial system. However, recent studies by our laboratory
(11, 45) and by others (24, 35, 40)
have shown that stress-related injury, including burn trauma,
hemorrhage, endotoxin challenge, and sepsis promote TNF-
synthesis
within several peripheral tissues, particularly the heart. The
contribution of local TNF-
synthesis to organ injury has remained
speculative, but strategies that inhibited TNF-
release or
neutralized TNF-
have been shown to provide significant
cardioprotection and to improve outcome after several types of
ischemia and trauma (11, 24). Therefore, this
present study was designed to examine the hypothesis that HSD given as an early pharmacological intervention after burn trauma provides significant cardiac protection by altering cardiac cytokine secretion.
| |
METHODS AND MATERIALS |
|---|
|
|
|---|
Experimental model. Adult Wistar-Furth rats (320-350 g) were used in the present study. Animals were obtained from Harlan Laboratories (Houston, TX) and were conditioned in-house for 5-6 days with commercial rat chow and tap water available at will. All studies performed were conducted under a protocol approved by The University of Texas Southwestern Medical Center's Institutional Review Board for the care and handling of laboratory animals and conformed to all guidelines for animal care as outlined by the American Physiological Society and the National Institutes of Health.
Catheter placement and burn procedure.
Rats were anesthetized lightly with methoxyflurane 18-20 h before
the burn experiment. Body hair on the side, back, and neck was closely
clipped, and the neck region was treated with a surgical scrub. The
left carotid artery was exposed, a polyethylene catheter (PE-50) was
inserted into the artery, and the tip was advanced retrogradely to the
level of the aortic arch. In addition, the right external jugular vein
was exposed, and a PE-50 catheter was inserted for the administration
of fluids and drugs. The catheters were filled with heparinized saline
and exteriorized at the nape of the neck with silk sutures via a
subcutaneous tunnel. After catheter placement, rats were housed within
the laboratory in individual cages. Eighteen hours after catheter
placement, animals were deeply anesthetized with methoxyflurane and
secured in a constructed template device as previously described
(1), and the surface of the skin area exposed through an
aperture in the template was immersed in 100°C water for 12 s on
the back and upper sides. Use of the template limited the burned area,
avoided injury to the abdominal organs, and produced full-thickness
dermal burns over 40% of the total body surface area. Exposure
to this water temperature in adult rats has been shown previously by
our laboratory to destroy all underlying nerves, to produce a
well-circumscribed burn area, and to produce a transient
(<0.5°C) rise in internal body temperature for 30 s
after exposure to the 100°C water and an absence of injury to
underlying organs. Sham burn rats were subjected to identical
preparation, except that they were immersed in room temperature water
to serve as controls. After immersion, all rats were immediately dried
and placed in individual cages to recover from the anesthesia. Burned
rats did not display discomfort or pain, moved freely about the cage,
and consumed food and water within 20 min after the burn procedure.
Immediately after the animal was returned to a cage, the external
jugular catheter was connected to a swivel device (model 923, Holter
pump, Critikon; Tampa, FL) for fluid administration (lactated Ringer
solution, 4 ml/kg per percent burn by the Parkland formula) during the
postburn period (total volume of lactated Ringer solution given over
the first 24-h postburn was 50-56 ml/rat). In the sham burn group, the external jugular vein was cannulated and lactated Ringer solution (0.2 ml · kg
1 · h
1) was
given to maintain catheter patency. Body temperature was measured with
a rectal temperature probe (model 44TA, YSL-Tele Thermometer), and
respiratory rate was monitored by counting respiratory movement.
Systemic blood pressure was measured using a Gould-Statham pressure
transducer (model P23 ID, Gould Instruments; Oxnard, CA) connected to a
Grass medical recorder (model 7D, Polygraph, Grass Instruments; Quincy,
MA). A tachycardiograph (model 7P4F, Grass Instruments) was used to
monitor heart rate.
Experimental groups. Rats were randomly divided into sham and burn groups; in addition, sham burn rats were divided into two additional subgroups: one group was given a bolus of HSD (4 ml/kg body wt) to examine the cardiac effects of a hyperosmotic solution in the absence of burn trauma; the remaining sham burn animals received a bolus of isotonic saline (4 ml/kg body wt). Lactated Ringer solution was given in both sham groups to maintain catheter patency.
In rats given a full-thickness burn injury, fluid resuscitation was initiated with lactated Ringer solution 10 min after completing the burn trauma. The total volume of lactated Ringer solution was calculated as 4 ml/kg per percent burn, with one-half the calculated volume given over the first 8 h postburn and the remaining volume of lactated Ringer solution given over the next 16 h after burn (Parkland formula). Forty-five minutes after lactated Ringer solution resuscitation was initiated, burn rats were randomly divided to receive a bolus of either isotonic saline or HSD given as 4 ml/kg body wt. After the isotonic saline or HSD infusion was completed, lactated Ringer solution resuscitation was resumed. The initial fluid resuscitation was conducted to simulate lactated Ringer solution administration during patient transport in the Dallas/Fort Worth metropolitan area. The timing for administrating the isotonic saline or HSD infusion simulated in-hospital administration of HSD as previously described in our clinical studies (38). An aliquot of arterial blood was collected (via the carotid artery catheter) 24 h postburn for measurement of systemic cytokine levels (ELISA). Rats were then anticoagulated with heparin sodium (1,000 units, Elkin-Sinn; Cherry Hill, NJ) and decapitated, and hearts were harvested for in vitro studies. In this study, hearts harvested from each of four experimental groups described above were randomly selected to assess either ventricular function (Langendorff perfusion, n = 8 hearts/group) or were perfused in a Langendorff mode with collagenase-containing buffer to prepare cardiomyocytes (n = 6 hearts/group). These times were selected to examine the effects of HSD on burn-mediated cardiac contractile deficits and cardiomyocyte secretion of cytokines based on our previous studies showing that contractile dysfunction is maximal by 24 h postburn and persists over 36-40 h after burn injury.Isolated coronary perfused hearts.
The heart was rapidly removed and placed in ice-cold (4°C)
Krebs-Henseleit bicarbonate-buffered solution of (in mM) 118 NaCl, 4.7 KCl, 21 NaHCO3, 2.5 CaCl2, 1.2 MgSO4, 1.2 KH2PO4, and 11 glucose. All solutions were prepared each day with demineralized, deionized water and bubbled with 95% O2-5% CO2 (pH,
7.4; PO2, 550 mmHg; PCO2, 38 mmHg). A 17-gauge cannula was placed
in the ascending aorta and connected via glass tubing to a
buffer-filled reservoir for perfusion of the coronary circulation at a
constant flow rate. Hearts were suspended in a temperature-controlled
chamber maintained at 38 ± 0.5°C, and a constant flow pump
(model 911, Holter, Critikon) was used to maintain perfusion of the
coronary arteries by retrograde perfusion of the aortic stump cannula.
Coronary perfusion pressure was measured, and effluent was collected to
confirm coronary flow rate. Contractile function was assessed by
measuring intraventricular pressure with a saline-filled latex balloon
attached to a polyethylene tube and threaded into the left ventricular
chamber. Left ventricular developed pressure (LVDP) was measured with a
Statham pressure transducer (model P23 ID, Gould Instruments) attached
to the balloon cannula, and the rates of left ventricular pressure
(LVP) rise (+dP/dt) and fall (
dP/dt) were
obtained using an electronic differentiator (model 7P20C, Grass
Recording Instruments) and recorded (model 7DWL8P, Grass Recording
Instruments). Data from the Grass recorder were input to a Dell Pentium
computer, and a Grass PolyVIEW Data Acquisition System was used to
convert acquired data into digital form.
Cardiomyocyte isolation. All pipettes, plates, test tubes, and other equipment used for preparation and culture of cardiomyocytes were sterile. Culture media, cytokine solutions, and other solutions used for preparation and culture of the myocytes were endotoxin-free (determined by a chromogenic limulus amebocyte lysate assay, data not shown). Hearts were removed through a medial sternotomy using sterile techniques; the isolated heart was immediately placed in ice-cold calcium-free Tyrode's solution of (in mM) 136 NaCl, 5.36 KCl, 0.57 MgCl2, 0.33 NaH2PO4, 10 HEPES, and 10 glucose. The aorta was cannulated within 90 s, and the excised heart was perfused with Tyrode's solution using a Langendorff perfusion apparatus. The Tyrode's solution was equilibrated with 95% O2-5% CO2 during perfusion of the heart. Perfusion was maintained for 5 min, and ventricular drainage was ensured by placing a 22-gauge needle in each ventricle. Perfusion was then continued for an additional 10 min using a collagenase solution containing 80 ml of calcium-free Tyrode's solution, 40 mg collagenase A (0.05%, Boehringer Mannheim, Indianapolis, IN), and 0.4 mg of protease (Polysaccharide XIV, Sigma, St. Louis, MO) with continuous oxygenation. After this enzymatic digestion, the heart was removed from the cannula and the ventricular tissue was separated from the base of the heart in a petri dish containing Tyrode's solution with 100 µM calcium where gentle mincing increased cell dispersion over 5 min. The myocyte suspension was then filtered, and the cells were allowed to settle. The supernatant was removed, and the cells were resuspended in 50 ml of Tyrode's solution. The rinsing and settling step was repeated three times with 10 min between each step and with gentle swirling between each step to allow myocyte separation. The calcium concentration of the rinsing solution was gradually increased during these steps, with calcium concentrations of 100 µM, 200 µM, and finally 1.8 mM. Cell viability was measured (trypan blue dye exclusion); myocytes with a rodlike shape, clear-formed edges, and well-defined striations were prepared with a final cell number of 5 × 104 cells/ml (18, 25).
To further explore the effects of HSD resuscitation from burn injury on cardiomyocyte cytokine responsiveness, myocytes were isolated from all four experimental groups (sham plus isotonic saline, sham plus HSD, burns given lactated Ringer solution and isotonic saline, and burns given lactated Ringer solution and HSD) and suspended in Eagle's minimum essential medium containing 10% fetal bovine serum. Myocytes were placed using pipettes into microtiter plates (cell number of 5 × 104 myocytes per microtiter well) (12-well cell culture cluster, Corning; Corning, NY) and subsequently stimulated with either 0, 10, 25, or 50 µg/well of lipopolysaccharide (LPS) (lot 65H 4053, Escherichia coli, Difco Laboratories; Detroit, MI) for 18 h (CO2 incubator at 37°C). Supernatants were collected to measure myocyte-secreted TNF-
, interleukin (IL)-1
,
and IL-6 (TNF-
and IL-1
rat ELISA, Endogen, Woburn, MA; IL-6 rat
ELISA, BioSource, Camarillo, CA).
Intracellular calcium measurement.
Because previous studies have suggested that HSD may alter cardiac
contractile function by modulating intracellular calcium homeostasis,
intracellular Ca2+ concentration
([Ca2+]i) was measured at room temperature
with constant low stirring in a Hitachi F-2000 fluorescence
spectrophotometer (20). Fura 2-acetoxymethyl ester
(AM)-loaded myocytes were suspended in calcium-free saline and placed
in a 1-ml quartz cuvette; a magnetic stirring bar in the bottom of the
cuvette maintained the cells in suspension. The spectrophotometer was
equipped with a 150-W xenon lamp, an interference filter with a 20-nm
bandpass was used to establish the excitation wavelengths (340/380 nm),
and the emission light was collected through a 510-nm filter with a
10-nm bandpass at a response time of 0.5 s. The calibration
procedure included measuring fluorescence ratios with different calcium
concentration buffers. [Ca2+]i was measured
as a ratio (R) of two fluorescent signals (F1 and
F2) generated from the two excitation wavelengths (340 nm and 380 nm). Autofluorescence of myocytes that had not been loaded with
fura 2-AM (indicated in the formula as fluorescence background, Fbckg) was subtracted from fluorescence measured in
myocytes loaded with fura 2-AM (indicated in the formula as
F1,cell and F2,cell) as described by the
formula: R = (F1,cell
F1,bckg)/(F2,cell
F2,bckg)
and applied to the following equation of Grynkiewicz et al.
(13)
|
is the
ratio of fluorescence signals measured in calcium-free and
calcium-saturated cells measured at 380 nm (13, 18). R is
the ratio of fluorescence measured in cardiomyocytes at 340 and 380 nm,
and Rmin and Rmax are the minimal and maximal
ratios measured in calcium-free and calcium-saturated cells, respectively.
Contribution of emigrated leukocytes. To determine the presence of contaminating leukocytes that may have contributed to cytokine secretion measured in our cardiomyocyte cultures, cells were sorted on a Becton-Dickinson FACScan cytometer. Optimal settings for forward and side scatter, which correlate with cell size and cell complexity, respectively, were adjusted to distinguish different cell populations (6). Cardiac myocytes are ~40 times the size of leukocytes (5-10 µm), allowing separation of these cell populations based on size. In addition to FACScan, myocyte preparations were examined by hematoxylin and eosin staining and light microscopy to determine presence of contaminating leukocytes.
To determine whether leukocyte contamination was a major factor in cardiomyocyte TNF-
secretion after burn trauma, preliminary studies
described above estimated that our cardiomyocyte cultures could contain
a maximum of 1,000 leukocytes per microtiter well. Therefore,
polymorphonuclear neutrophils (PMNs) were isolated 24 h after
either burn trauma or sham burn from citrate anticoagulated blood using
techniques previously described by our lab (15). The
neutrophils were suspended in phosphate buffer solution, counted with a
hemacytometer, and plated in 48-well culture dishes to achieve a
concentration of leukocytes per well that would equal the greatest
number of leukocytes that could contaminate cardiomyocyte preparations
as determined by fluorescence-activated cell sorter (FACS)
analysis and light microscopy. Light microscopy showed that <2% of
the total cell number in the myocyte preparations was leukocytes,
resulting in a maximum of 1,000 leukocytes per microtiter well. The
plated leukocytes were then stimulated with LPS (0, 10, 25, and 50 µg/well) as described for cardiomyocytes for 18 h, supernatants
were harvested, and TNF-
produced by noncardiomyocyte cells was
measured by ELISA.
Statistical analysis. All values are expressed as means ± SE. ANOVA was used to assess an overall difference among the groups for each of the variables. Levene's test for homogeneity of variance was used to suggest the multiple comparison procedure to be used. If equality of variance among the four groups was suggested, multiple comparison procedures were performed (Bonferroni); if inequality of variance was suggested by Levene's test, Tamhane multiple comparisons (which do not assume equal variance in each group) were performed. A P value <0.05 was considered statistically significant (analysis was performed using SPSS for Windows, Version 7.5.1).
| |
RESULTS |
|---|
|
|
|---|
All animals survived the respective experimental protocols. HSD
reduced heart rate in sham burns (P < 0.05) (Table
1), whereas there were no metabolic or
hemodynamic effects of HSD in this experimental group measured 24 h postburn (Tables 1 and 2). In addition,
left ventricular function curves calculated for HSD-treated shams were
nearly identical to those measured in isotonic-treated shams (Fig.
1). Burn trauma was associated with a
lower mean arterial blood pressure 24 h postinjury, regardless of
HSD administration. In addition, hematocrit was lower in all burn rats
at this time, likely due to the hemodilutional effects of volume
resuscitation. The lower PCO2 and
HCO
and IL-1
levels were elevated 24 h postburn in
rats given standard lactated Ringer solution resuscitation (Table 1),
but HSD administration after burn injury attenuated the levels of
systemic inflammatory cytokines TNF-
and IL-1
.
|
|
|
Cardiac contraction and relaxation deficits were evident in burns given
a bolus of isotonic saline followed by standard lactated Ringer
solution resuscitation as indicated by the lower LVP and maximum
+dP/dt and minimum
dP/dt (Table 2). In
contrast, LVP and maximum +dP/dt were higher in HSD-treated
burns compared with values measured in lactated Ringer
solution-resuscitated burn rats. Cardiac contractile performance was
further examined by plotting LVP and maximum ±dP/dt versus
incremental increases in preload or left ventricular volume. Consistent
with our previous studies in burned guinea pigs (11),
cardiac contractile depression was evident in burn rats given standard
lactated Ringer solution resuscitation as indicated by the downward and
rightward shift of left ventricular function curves; these contractile
deficits occurred despite aggressive lactated Ringer solution
resuscitation over 24 h postburn. In contrast, an initial HSD
infusion in the early postburn period significantly improved cardiac
contraction and relaxation despite an identical total volume of fluid
administered during the 24-h postburn. Similarly, measures of
contractile performance (LVP and maximum ±dP/dt) plotted
versus incremental increases in either coronary flow rate (Fig.
2) or perfusate calcium (Fig. 3) were always higher in HSD-treated
burns compared with values measured in burns given standard care
lactated Ringer solution resuscitation. The HSD-mediated improvement in
ventricular responses to either coronary flow rate or perfusate
calcium, confirm our previous findings with HSD administration in a
guinea pig model of burn trauma and suggest that early postburn
administration of HSD provides cardiac contraction and relaxation
benefits that persist for at least 24 h after injury and fluid
resuscitation.
|
|
Figure 4 summarizes TNF-
(left), IL-1
(middle), and IL-6
(right) concentrations measured in the supernatants of
myocytes harvested from either shams, shams given HSD, burns given
standard lactated Ringer solution resuscitation, and burns given HSD
and lactated Ringer solution. Cardiomyocyte secretion of TNF-
,
IL-1
, and IL-6 was significantly higher (P < 0.05)
in isotonic saline and lactated Ringer solution-resuscitated burns
compared with values measured in sham burns. However, HSD
administration after burn trauma ablated this burn-enhanced TNF-
and
interleukin secretion by cardiomyocytes.
|
In addition, cardiomyocytes (50,000 cells) from all experimental groups
were challenged in vitro with either 0, 10, 25, or 50 µg/well of LPS
for 18 h. As shown in Fig. 5,
myocytes from sham burns responded to LPS challenge with a dose-related
increase in TNF-
secretion (P < 0.05). However,
myocytes prepared from isotonic saline-lactated Ringer-treated burns
secreted significantly more TNF-
at each LPS dose compared with
responses measured in myocytes from sham burns (P < 0.05). In contrast, HSD treatment of burn trauma significantly
attenuated the LPS-induced secretion of TNF-
by cardiomyocytes
(P < 0.05); myocytes from HSD-treated rats (both
burned and sham) secreted minimal TNF-
at all LPS doses.
|
Similarly, myocytes from sham burns responded to in vitro LPS challenge
with dose-dependent increases in IL-1
and IL-6 secretion; however,
burn trauma exacerbated cardiomyocyte secretion of IL-1
(Fig.
6) and IL-6 (Fig.
7) with LPS stimulus. In contrast, the administration of HSD after burn trauma decreased myocyte secretion of
IL-1
and IL-6 in response to LPS challenge. Thus myocytes from burns
resuscitated with standard care lactated Ringer solution secreted
significantly more TNF-
, IL-1
, and IL-6 compared with levels
measured in HSD-treated burns.
|
|
Examination of the cardiomyocyte preparation by FACScan confirmed that >93% of the cells were myocytes based on size. Examination of aliquots of these myocyte preparations by light microscopy determined that 93% of the cells were viable cardiomyocytes, 4% were dead cardiomyocytes, and <2% of the total cell population were neutrophils.
Figure 8 examines TNF-
secretory
capacity of neutrophils (1 × 103 PMNs per microtiter
well) stimulated with 0, 10, 25, and 50 µg LPS/well as described for
the cardiomyocyte studies. This number of PMNs per well was based on
the FACS analysis and light microscopy showing that <2% of our cell
preparation was PMNs. These preliminary studies showed that the maximal
number of PMNs that could contaminate our cardiomyocyte preparations
was 1 × 103 cells per microtiter well. Our data
confirmed that PMNs respond to LPS challenge by secreting TNF-
and
this response was exacerbated by previous burn trauma (Fig. 8).
However, the maximum TNF-
levels secreted by this PMN population
could not account for the TNF-
levels measured in our myocyte
preparation. For example, cardiomyocytes (5 × 104) prepared from burn rats secreted 4,880 ± 300 pg/ml TNF-
when challenged with LPS (50 µg/well). In contrast, an
identical LPS challenge (50 µg/well) of leukocytes produced 244 ± 20 pg/ml of TNF. Thus contamination of our myocyte preps with PMNs
would contribute to <5% of the total TNF-
secreted.
|
Finally, burn trauma promoted calcium accumulation in cardiomyocytes 24 h postburn (myocytes from sham burns, 93 ± 6 nM; myocytes from lactated Ringer solution-resuscitated burns, 293 ± 16 nM; P < 0.05). In contrast, HSD plus the administration of lactated Ringer solution significantly reduced the burn-related rise in cardiomyocyte calcium concentrations (123 ± 23 nM), whereas HSD in sham burns did not alter cardiomyocyte calcium levels (90 ± 12 nM).
| |
DISCUSSION |
|---|
|
|
|---|
Our studies confirm that major burn injury promotes cytokine
secretion by cardiomyocytes, producing significant cardiac levels of
TNF-
, IL-1
, and IL-6. Our studies further confirmed that the LPS
challenge of isolated cardiomyocytes evoked a robust cytokine secretory
response, and a previous burn injury exacerbated this proinflammatory
cytokine response of cardiomyocytes. It was of interest that
cardiomyocytes from burns resuscitated with a bolus of isotonic saline
plus lactated Ringer solution secreted significantly more TNF-
,
IL-1
, and IL-6 than sham cardiomyocytes at each LPS dose, suggesting
that an initial injury such as burn trauma primes this cell population
and exaggerates the inflammatory responses to a secondary stimulus such
as LPS challenge. In our study, the burn-related increase in
cardiomyocyte TNF-
, IL-1
, and IL-6 secretion was paralleled by
profound cardiac contractile dysfunction. These data suggest that local
cardiac synthesis of inflammatory cytokines could contribute, in part,
to the postburn cardiac contraction and relaxation deficits that occur
after major burn trauma.
In our study, plasma levels of IL-1
rose significantly in burns
given standard isotonic saline followed by lactated Ringer resuscitation from burn trauma. Whereas plasma TNF-
levels tended to
increase 24 h postburn in this experimental group, these changes did not achieve statistical significance. The finding of a higher myocardial TNF-
level compared with that measured in the systemic circulation supports our hypothesis that cardiomyocyte secretion of
TNF-
may produce myocardial cytokine levels that exceed those measured in the systemic circulation. Whereas circulating IL-1
levels were higher than those measured in the cardiac compartment, it
is likely that the high levels of TNF-
within the myocardium coupled
with increased local synthesis of IL-1
could contribute to the
detrimental effect on cardiac myocyte function. It was of interest that
HSD administration attenuated burn-related TNF-
, IL-1
, and IL-6
secretion by cardiomyocytes, and these downregulated inflammatory
cytokine responses were paralleled by a remarkable improvement in
postburn cardiac contraction and relaxation.
For the past 30 years, there has been considerable debate regarding the advantages and disadvantages of crystalloid versus colloid resuscitation from trauma, and numerous studies have described the limitations and advantages of each resuscitation treatment (3, 10, 28-30, 32, 36, 42, 46). Because approximately one-third of the infused crystalloid solution remains within the vascular space, a large volume of crystalloid solution is required to adequately replace volume losses in the burn patient with significant fluid redistribution. The marked accumulation of crystalloid fluid in the extravascular compartment produces tissue edema, raising concerns that large-volume crystalloid infusion may compromise pulmonary function and promote the development of respiratory distress syndrome (28, 30, 31). Others have expressed concern that aggressive crystalloid resuscitation after trauma may promote myocardial edema. The resulting compression of coronary endothelial vessels could produce areas of relative myocardial ischemia, contributing to postburn cardiac dysfunction (7, 44). One advantage of colloids is the significant reduction in total fluid requirements, but concerns include the burn-related changes in endothelial barrier function, inhibition of normal hemostasis, long-term retention of colloids within the body, and the occurrence of anaphylactoid reactions (2, 8, 34).
Whereas crystalloid resuscitation of burn trauma has been used successfully for the last 35 years with few complications, recent studies have raised additional questions about the effects of lactated Ringer solution on immunologic function after trauma. In this regard, Rhee and colleagues (43) showed that large-volume crystalloid resuscitation from hemorrhagic shock increased expression of the intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 and produced pulmonary edema and inflammatory cell infiltration compared with that seen with HSD resuscitation. It is well recognized that neutrophil activation and adherence and suppressed T-cell function occur after trauma including burn injury, and impaired immune defenses may contribute to posttrauma complications such as pneumonia and sepsis. Junger and colleagues (22, 23) showed that moderately hypertonic salt solutions enhanced T-cell proliferation. The hypertonic solution described by Junger contained salt concentrations corresponding to plasma sodium levels produced by trauma resuscitation with the 4 ml/kg dose of a 7.5% NaCl solution. This rescue of T cells from trauma-mediated suppression has been proposed to improve cellular immune function, providing immunologic protection against trauma-related complications such as sepsis and pneumonia. Whereas crystalloids have been routinely used for resuscitation of major burn injury, these recent studies suggest that the type of fluid used for resuscitation is not innocuous and may indeed exacerbate the burn-mediated inflammatory cascade.
These studies by Rhee and colleagues (43) and Junger and associates (22, 23) stimulated our interest in the effects of HSD resuscitation from burn trauma on the cardiac inflammatory responses. We previously showed that small-volume HSD, given within 6 h after a major burn injury in both clinical and experimental burns, significantly improved cardiac performance and reduced serum troponin I levels compared with values measured in subjects given standard crystalloid resuscitation (20, 21, 38). However, the mechanisms by which HSD reduced cardiomyocyte injury and improved cardiac contractile function has remained elusive.
The physiological effects of HSD have been attributed primarily to its effectiveness as a small-volume expander (9, 14, 20, 26). A previous study (26) suggests that each milliliter of hypertonic saline expands plasma volume by ~3 ml due to the osmotic effects of concentrated sodium chloride in retrieving water from the cellular space, whereas the dextran component retains fluid within the vascular space. Other studies (4, 26, 33, 37) have attributed the effectiveness of HSD resuscitation to hyperosmotic vasodilation of both the pulmonary and systemic microcirculation, improved venous return (Frank-Starling mechanism), or peripheral vasodilation and reduced afterload. Our previous study (16) confirmed a postburn decrease in coronary blood flow despite aggressive crystalloid resuscitation, and we initially attributed the beneficial effects of HSD in burn trauma to improved coronary perfusion. In this regard, Mazonni and colleagues (33) showed that hypertonic solutions promoted vasodilation and decreased reperfusion-related injury. Whereas HSD may improve cardiac performance secondary to improving coronary perfusion, this present study focused on the effects of HSD resuscitation from burn trauma on the cardiomyocyte secretion of inflammatory cytokines.
Although the intracellular signaling mechanisms by which burn trauma
promotes cardiomyocyte secretion of TNF-
, IL-1
, and IL-6 remain
unclear, recent studies from our laboratory have shown that burn trauma
promotes free radical-mediated cell membrane peroxidation, neutrophil
adherence and activation within the coronary microcirculation, and
emigration of activated leukocytes into the myocardial tissue
(15, 19). These findings raised a concern in our present
study that emigrating neutrophils could contaminate our cardiomyocyte
preparations and PMN-derived cytokines could contribute to the measured
cytokine levels. In our study, even the maximal number of PMNs,
calculated from FACS analysis of cardiomyocyte preparations, failed to
account for the TNF-
levels measured in cardiomyocyte supernatants.
These data minimized concerns regarding the potential contamination of
cardiomyocytes by neutrophils and suggest that the secreted TNF-
levels were directly attributable to cardiomyocytes per se.
In this study, HSD administration after burn trauma prevented the rise in intracellular calcium concentration observed in burns given standard lactated Ringer resuscitation, a finding consistent with Junger's description (22, 23) of hypertonic-mediated suppression of calcium mobilization by T cells. It is likely that the decrease in inflammatory cytokine secretion observed in our study may be the direct result of normalization of [Ca2+]i and stabilization of sarcolemma membrane potential. After crystalloid resuscitation of burn trauma, [Ca2+]i was threefold higher in cardiac myocytes compared with that observed in cardiac myocytes from sham burns. Secretion of inflammatory cytokines is likely a calcium-dependent process. If the mechanism of LPS-stimulated secretion of cytokines is calcium independent, the presence of an elevated intracellular calcium level coupled with partially depolarized cell membrane potentials after burn trauma may increase synthesis via protein kinase C, increasing sensitivity for LPS-evoked secretion. We have recently shown (unpublished data) that burn trauma resuscitated with lactated Ringer solution promotes a partial depolarization of the sarcolemma transmembrane potential, and this depolarization was ablated with HSD treatment of burn trauma. These later data are consistent with HSD-mediated changes in transmembrane ion transport as described by Nakayama and colleagues (39). Therefore, it is likely that HSD alters cardiac cytokine secretion by several mechanisms including stabilization of the transmembrane potential and a decrease in transsarcolemma calcium flux which, in turn, may play a critical role in downregulating several intracellular kinases (protein kinase C and p38 mitogen-activated protein kinase) thought to play a critical role in signal transduction mechanisms that regulate transcription and/or translation of inflammatory cytokines (35).
In summary, our data suggest that HSD mediates cardioprotection in part
after burn trauma by decreasing cardiomyocyte secretion of inflammatory
cytokines. Whereas burn trauma increased secretion of inflammatory
cytokines (TNF-
, IL-1
, and IL-6) that may contribute to postburn
cardiac dysfunction, the signal transduction mechanisms that regulate
cytokine transcription and/or translation remain unknown in the setting
of burn trauma. Our finding that HSD administration in the early
postburn period downregulated cytokine secretion by cardiomyocytes was
particularly important because locally produced cytokines within the
myocardial tissue may not be buffered by circulating or soluble
receptors that would have limited access to intramyocardially produced
cytokines. Thus locally secreted TNF-
and interleukins may have
detrimental consequences on cardiomyocyte membrane integrity,
contributing to myocyte injury, and altering cardiac performance.
However, it is likely that HSD improved cardiac performance by
interrupting several aspects of the inflammatory cascade that
culminated in increased TNF-
and interleukin secretion, perhaps by
reducing burn-mediated oxygen free radical generation or decreasing
neutrophil adherence and activation. From these considerations, the
beneficial cellular effects of HSD on burn trauma warrant further study.
| |
ACKNOWLEDGEMENTS |
|---|
This study was supported by the National Institutes of Health, Burn Center Grant GM-21681.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: J. W. Horton, Dept. of Surgery, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390-9160 (E-mail: JURETA.HORTON{at}utsouthwestern.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 11 February 2000; accepted in final form 17 October 2000.
| |
REFERENCES |
|---|
|
|
|---|
1.
Adams, HR,
Baxter CR,
Parker JL,
and
Senning R.
Development of acute burn shock in unresuscitated guinea pigs.
Circ Shock
8:
613-620,
1981[Web of Science][Medline].
2.
Adelson, E,
Crosby W,
and
Roeder WH.
Further studies of hemostatic defect caused by intravenous dextran (Abstract).
J Lab Clin Med
45:
441,
1955.
3.
Blajchman, MA,
Bordin JO,
Bardossy L,
and
Heddle NM.
The contribution of the haematocrit to thrombocytopenic bleeding in experimental animals.
Br J Haematol
86:
347-350,
1994[Web of Science][Medline].
4.
Brown, JM,
Grosso MA,
and
Moore EE.
Hypertonic saline and dextran: impact on cardiac function in the isolated rat heart.
J Trauma
30:
646-651,
1990[Web of Science][Medline].
5.
Coimbra, R,
Hoyt DB,
Junger WG,
Angle N,
Wolf P,
Loomis W,
and
Evers MF.
Hypertonic saline resuscitation decreases susceptibility to sepsis after hemorrhagic shock.
J Trauma
42:
602-607,
1997[Web of Science][Medline].
6.
Coligan, JE,
Krusbeek AM,
Margulies DH,
Shevach EM,
and
Strober W.
Current Protocols in Immunology. New York: Wiley, 1995, p. 5.1-5.4.
7.
Conahan, ST,
Dupre A,
Giaimo ME,
Fowler CA,
and
Torres CS.
Resuscitation fluid composition and myocardial performance during burn shock.
Circ Shock
23:
37-49,
1987[Web of Science][Medline].
8.
Dahn, MS,
Lucas CE,
Ledgerwood AM,
and
Higgins RF.
Negative inotropic effect of albumin resuscitation for shock.
Surgery
86:
235-241,
1979[Web of Science][Medline].
9.
Dubick, MA,
and
Wade CE.
A review of the efficacy and safety of 7.5% NaCl/6% Dextran 70 in experimental animals and in humans.
J Trauma
36:
323-329,
1994[Web of Science][Medline].
10.
Gattinoni, L,
Mascheroni D,
Torresin A,
Marcolin R,
Fumagalli R,
Vesconi S,
Rossi GP,
Rossi F,
Baglioni S,
and
Bassi F.
Morphologic response to PEEP in acute perspiratory failure. Computerized tomography study.
Intensive Care Med
12:
137-142,
1986[Web of Science][Medline].
11.
Giroir, BP,
Horton JW,
White DJ,
McIntyre KL,
and
Lin CQ.
Inhibition of tumor necrosis factor prevents myocardial dysfunction during burn shock.
Am J Physiol Heart Circ Physiol
267:
H118-H124,
1994
12.
Greene, SP,
Soucy DM,
Song WC,
Barber AE,
Hagedorn FN,
Illner HP,
and
Shires GT.
Early isotonic saline resuscitation from uncontrolled hemorrhage in rats.
Surgery
124:
568-574,
1998[Web of Science][Medline].
13.
Grynkiewicz, G,
Poenie M,
and
Tsien RY
A new generation of Ca2+ indicators with greatly improved fluorescence properties.
J Biol Chem
260:
3440-3450,
1985
14.
Holcroft, JW,
Vassar MJ,
Turner JE,
Derlet RW,
and
Kramer GC.
3% NaCl and 7.5% NaCl/Dextran 70 in the resuscitation of severely injured patients.
Ann Surg
206:
279-288,
1987[Web of Science][Medline].
15.
Horton, JW.
Cellular basis for burn-mediated cardiac dysfunction in adult rabbits.
Am J Physiol Heart Circ Physiol
271:
H2615-H2621,
1996
16.
Horton, JW.
Contribution of decreased coronary blood flow to postburn cardiac deficits (Abstract).
FASEB J
13:
A756,
1999.
17.
Horton, JW,
Dunn CW,
Burnweit C,
and
Walker PB.
Hypertonic saline dextran resuscitation of acute bile-induced pancreatitis.
Am J Surg
158:
48-56,
1989[Web of Science][Medline].
18.
Horton, JW,
Lin C,
and
Maass D.
Burn trauma and tumor necrosis factor
alter calcium handling by cardiomyocytes.
Shock
10:
270-277,
1998[Web of Science][Medline].
19.
Horton, JW,
Mileski WJ,
White DJ,
and
Lipsky P.
Monoclonal antibody to intercellular adhesion molecule-1 reduces cardiac contractile dysfunction after burn injury in rabbits.
J Surg Res
64:
49-56,
1996[Web of Science][Medline].
20.
Horton, JW,
White DJ,
and
Baxter CR.
Hypertonic saline dextran resuscitation of thermal injury.
Ann Surg
211:
301-311,
1990[Web of Science][Medline].
21.
Horton, JW,
White DJ,
and
Hunt JL.
Delayed hypertonic saline dextran administration after burn injury.
J Trauma
38:
281-286,
1995[Web of Science][Medline].
22.
Junger, WG,
Coimbra R,
Liu FC,
Herdon-Remelius C,
Junger W,
Junger H,
Loomis W,
Hoyt DB,
and
Altman A.
Hypertonic saline resuscitation: a tool to modulate immune function in trauma patients?
Shock
8:
235-241,
1997[Web of Science][Medline].
23.
Junger, WG,
Hoyt DB,
Hamreus M,
Liu FC,
Herdon-Remelius C,
Junger W,
and
Altman A.
Hypertonic saline activates protein tyrosine kinases and mitogen-activated protein kinase p38 in T-cells.
J Trauma
42:
437-443,
1997[Web of Science][Medline].
24.
Kapadia, S,
Lee J,
Torre-Amione G,
Birdsall HH,
Ma TS,
and
Mann DL.
Tumor necrosis factor-
gene and protein expression in adult feline myocardium after endotoxin administration.
J Clin Invest
96:
1042-1052,
1995.
25.
Keller, RS,
Parker JL,
Adams HR,
and
Rubin LJ.
Contractile dysfunction and inositol phosphates in ventricular myocytes isolated from endotoxemia guinea pigs.
Circ Shock
37:
29,
1992.
26.
Kramer, GC,
Perron PR,
Lindsey DC,
Ho HS,
Gunther RA,
and
Boyle WA.
Small volume resuscitation with hypertonic saline dextran solution.
Surgery
100:
239-246,
1986[Web of Science][Medline].
27.
Lilly, MP,
Gala GJ,
Carlson DE,
Sutherland BE,
and
Gann DS.
Saline resuscitation after fixed-volume hemorrhage.
Ann Surg
126:
161-171,
1992.
28.
Lowell, JA,
Schifferdecker C,
Driscoll DF,
Benotti PN,
and
Bistrian BR.
Post-operative fluid overload: not a benign problem.
Crit Care Med
18:
728-733,
1990[Web of Science][Medline].
29.
Lucas, CE,
Martin DJ,
Ledgewood AM,
Hoschner J,
McGonigal MD,
Kithier K,
and
Sardesai VM.
Effect of fresh-frozen plasma resuscitation on cardiopulmonary function and serum protein flux.
Arch Surg
121:
559-596,
1986
30.
Lyons, WS.
Rhyme, reason, and Ringer's lactate.
Virginia Pul J
3:
4,
1997.
31.
Maier, RV,
and
Bolger EM.
Endothelial changes after shock and injury.
New Horiz
4:
211-223,
1996[Medline].
32.
Marcus, AJ.
Thrombosis and inflammation as multicellular processes: patho-physiologic significance of transcellular metabolisms.
Blood
76:
1903-1907,
1990
33.
Mazzoni, MC,
Borgstrom P,
Intaglietta M,
and
Arfors KE.
Capillary narrowing in hemorrhagic shock is rectified by hyperosmotic saline-dextran reinfusion.
Circ Shock
31:
407-418,
1990[Web of Science][Medline].
34.
McIntyre, E,
Mackie IJ,
Ho D,
Tinker J,
Bullen C,
and
Machin SJ.
The haemostatic effects of dydroxyethyl starch (HES) used as a volume expander.
Intensive Care Med
11:
300-303,
1985[Web of Science][Medline].
35.
Meldrum, DR.
Tumor necrosis factor in the heart.
Am J Physiol Regulatory Integrative Comp Physiol
274:
R577-R595,
1998
36.
Mendelsohn, ME,
O'Neill S,
George D,
and
Loscalzo J.
Inhibition of fibrinogen binding to human platelets by S-nitroso-N-acetylcysteine.
J Biol Chem
265:
19028-19034,
1990
37.
Moore, EE.
Hypertonic saline dextran for post-injury resuscitation: experimental background and clinical experience.
Aust NZ J Surg
61:
732-736,
1991[Web of Science][Medline].
38.
Murphy, JT,
Horton JW,
Purdue GF,
and
Hunt JL.
Evaluation of troponin-I as an indicator of cardiac dysfunction after thermal injury.
J Trauma
45:
700-704,
1998[Web of Science][Medline].
39.
Nakayama, SI,
Kramer GC,
Carlsen RC,
and
Holcroft JW.
Infusion of very hypertonic saline to bled rats: membrane potentials and fluid shifts.
J Surg Res
38:
180-186,
1985[Web of Science][Medline].
40.
Oral, H,
Dorn GW, II,
and
Mann DL.
Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor-
in the adult mammalian cardiac myocyte.
J Biol Chem
272:
4836-4842,
1997
41.
Pascual, JM,
Watson JC,
Runyon AE,
Wade CE,
and
Kramer GC.
Resuscitation of intraoperative hypovolemia: a comparison of normal saline and hyperosmotic hyperoncotic solutions in swine.
Crit Care Med
20:
200-210,
1992[Web of Science][Medline].
42.
Pope, A,
French G,
and
Longnecker DE.
Fluid Resuscitation: State of the Science for Treating Combat Casualties and Civilian Injuries. Washington, DC: National Academy Press, 1999, p. 47-76.
43.
Rhee, P,
Wang D,
Ruff P,
Austin B,
DeBraux S,
Wolcott K,
Burris C,
Ling G,
and
Sun L.
Human neutrophil activation and increased adhesion by various resuscitation fluids.
Crit Care Med
28:
74-78,
2000[Web of Science][Medline].
44.
Szabo, K.
Cardiac support in burned patients with heart disease.
Acta Chir Plast
31:
22-34,
1989[Medline].
45.
Turbeville, T,
and
Horton JW.
Burn trauma stimulates cardiomyocyte production of TNF-
and nitric oxide (NO).
Shock
9, Suppl:
8,
1998.
46.
Valeri, CR,
Crowley JP,
and
Loscalzo J.
The red cell transfusion trigger: has a sin of commission now become a sin of omission?
Transfusion
38:
602-608,
1998[Web of Science][Medline].
47.
Velasco, IT,
Rocha de Silva M,
Oliviera MA,
and
Silva RI.
Hypertonic and hyperoncotic resuscitation from severe hemorrhagic shock in dogs. A comparative study.
Crit Care Med
17:
261-264,
1989[Web of Science][Medline].
48.
Wade, CE,
Hannon JP,
Bossone CA,
and
Hunt MM.
Superiority of hypertonic saline/dextran over hypertonic saline during the first 30 min of resuscitation following hemorrhagic hypotension in conscious swine.
Resuscitation
20:
49-56,
1990[Web of Science][Medline].
This article has been cited by other articles:
![]() |
E. Grandi, M. Govoni, S. Furini, S. Severi, E. Giordano, A. Santoro, and S. Cavalcanti Induction of NO synthase 2 in ventricular cardiomyocytes incubated with a conventional bicarbonate dialysis bath Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2192 - 2197. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Kolsen-Petersen, K. Bendtzen, and E. Tonnesen Infusion of hypertonic saline before elective hysterectomy: effects on cytokines and stress hormones Br. J. Anaesth., April 1, 2008; 100(4): 478 - 484. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Horton, J. Tan, D. J. White, and D. L. Maass Burn injury decreases myocardial Na-K-ATPase activity: role of PKC inhibition Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1684 - R1692. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Horton, D. L. Maass, D. J. White, and J. P. Minei Bactericidal/permeability increasing protein attenuates the myocardial inflammation/dysfunction that occurs with burn complicated by subsequent infection J Appl Physiol, September 1, 2007; 103(3): 948 - 958. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Carlson, D. L. Maass, J. White, P. Sikes, and J. W. Horton Caspase inhibition reduces cardiac myocyte dyshomeostasis and improves cardiac contractile function after major burn injury J Appl Physiol, July 1, 2007; 103(1): 323 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tan, D. L. Maass, D. J. White, and J. W. Horton Effects of burn injury on myocardial signaling and cytokine secretion: possible role of PKC Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R887 - R896. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Carlson, D. L. Maass, D. J. White, J. Tan, and J. W. Horton Antioxidant vitamin therapy alters sepsis-related apoptotic myocardial activity and inflammatory responses Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2779 - H2789. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Horton, D. L. Maass, and D. J. White Hypertonic saline dextran after burn injury decreases inflammatory cytokine responses to subsequent pneumonia-related sepsis Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1642 - H1650. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Chagnon, C. N. Metz, R. Bucala, and O. Lesur Endotoxin-Induced Myocardial Dysfunction: Effects of Macrophage Migration Inhibitory Factor Neutralization Circ. Res., May 27, 2005; 96(10): 1095 - 1102. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Maass, J. White, B. Sanders, and J. W. Horton Role of cytosolic vs. mitochondrial Ca2+ accumulation in burn injury-related myocardial inflammation and function Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H744 - H751. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Horton, J. Tan, D. J. White, D. L. Maass, and J. A. Thomas Selective decontamination of the digestive tract attenuated the myocardial inflammation and dysfunction that occur with burn injury Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2241 - H2251. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Lang, R. A. Frost, and T. C. Vary Thermal injury impairs cardiac protein synthesis and is associated with alterations in translation initiation Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2004; 286(4): R740 - R750. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Horton, D. J. White, and D. L. Maass Gender-related differences in myocardial inflammatory and contractile responses to major burn trauma Am J Physiol Heart Circ Physiol, January 1, 2004; 286(1): H202 - H213. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. White, D. L. Carlson, M. Thompson, D. L. Maass, B. Sanders, B. Giroir, and J. W. Horton Molecular and pharmacological approaches to inhibiting nitric oxide after burn trauma Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1616 - H1625. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. White, J. Thomas, D. L. Maass, and J. W. Horton Cardiac effects of burn injury complicated by aspiration pneumonia-induced sepsis Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H47 - H58. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Carlson, D. J. White, D. L. Maass, R. C. Nguyen, B. Giroir, and J. W. Horton Ikappa B overexpression in cardiomyocytes prevents NF-kappa B translocation and provides cardioprotection in trauma Am J Physiol Heart Circ Physiol, March 1, 2003; 284(3): H804 - H814. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Perera and K. Porter The role of hypertonic saline dextran in trauma resuscitation Trauma, October 1, 2002; 4(4): 189 - 201. [Abstract] [PDF] |
||||
![]() |
J. A. Thomas, M. F. Tsen, D. J. White, and J. W. Horton TLR4 inactivation and rBPI21 block burn-induced myocardial contractile dysfunction Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1645 - H1655. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cuschieri, D. Gourlay, I. Garcia, S. Jelacic, and R. V. Maier Hypertonic Preconditioning Inhibits Macrophage Responsiveness to Endotoxin J. Immunol., February 1, 2002; 168(3): 1389 - 1396. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Sikes, P. Zhao, D. L. Maass, and J. W. Horton Time course of myocardial sodium accumulation after burn trauma: a 31P- and 23Na-NMR study J Appl Physiol, December 1, 2001; 91(6): 2695 - 2702. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |